Tag
This article reviews a cohort study characterizing the clinical features, complications, and developmental challenges in children with Zika-related microcephaly during the first five years after birth, highlighting the severity and scope of
Rapid whole-genome sequencing (WGS) in pediatric neurology inpatients yields nearly 50% diagnostic confirmation, significantly influencing patient management and supporting early genomic testing beyond neonatal intensive care units.
The NEAT phase 3 trial evaluated erythrocyte-encapsulated dexamethasone sodium phosphate in children with ataxia telangiectasia aged 6–9 years, confirming safety but failing to demonstrate statistically significant neurological improvement
A new study suggests vamorolone may preserve motor benefits seen with standard steroids in Duchenne muscular dystrophy while better protecting growth, though weight gain remains a concern.
Case series reports acute axonal neuropathy post-infection in children with biallelic RCC1 variants, often misdiagnosed as Guillain-Barré syndrome, showing variable severity and highlighting impaired nucleocytoplasmic transport as pathogeni
